瑞普生物：8月8日召开董事会会议

Group 1 - The company, Reap Bio, announced the convening of its 25th temporary board meeting on August 8, 2025, to discuss the proposal for the fourth temporary shareholders' meeting of 2025 [2] - For the year 2024, the revenue composition of Reap Bio is as follows: veterinary biological products account for 43.12%, veterinary drugs account for 33.86%, pet supply chain accounts for 20.63%, and others account for 2.38% [2]